ICAM1 and neoplasm: Through inhibiting LFA-1-ICAM-1 interaction, endocan secreted from NPC tumor cells may inhibit infiltration of leukocytes into tumor tissues and block the tumor-killing effect of cytotoxic lymphocytes and natural killer cells, leading to tumor development.